(Q42994697)

12 November 2017

Immunotherapy of cancer: key findings and commentary on the third Tegernsee conference (English)

1 reference

12 November 2017

1 reference

6

Bernard A Fox

1 reference

12 November 2017

Dominik Rüttinger

1

1 reference

12 November 2017

Hauke Winter

2

1 reference

12 November 2017

Natasja K van den Engel

3

1 reference

12 November 2017

Rudolf Hatz

4

1 reference

12 November 2017

Karl-Walter Jauch

5

1 reference

12 November 2017

Jeffrey S Weber

7

1 reference

12 November 2017

8 January 2010

1 reference

12 November 2017

1 reference

12 November 2017

15

1 reference

12 November 2017

1

1 reference

12 November 2017

112-118

1 reference

Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

Targeting angiogenesis in the treatment of lung cancer

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227889

10.1634/THEONCOLOGIST.2009-0213

26 May 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference

12 November 2017

PubMed publication ID

20061401

1 reference